Inhibitors of SARM1 in combination with neuro-protective agents
US12083114B2 · kind B2 · utility
1Cited by
99References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 18, 2019 |
| Grant date | Sep 10, 2024 |
| Priority date | — |
| Expiry date | Dec 17, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to methods of treating neurodegeneration and neurodegenerative diseases comprising administering to a subject in need thereof a combination of a SARM1 inhibitor and a neuroprotective agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.